Synacthen 0.25mg/1mL injection ampoule Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

synacthen 0.25mg/1ml injection ampoule

atnahs pharma australia pty ltd - tetracosactide, quantity: 0.25 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; acetic acid; sodium acetate - indications as at 12 august 1999: as a diagnostic aid in the assessment of suspected adrenocortical hypofunction.

CORTROSYN INJ 0.25MG POWDER FOR SOLUTION Kanada - Ingliż - Health Canada

cortrosyn inj 0.25mg powder for solution

amphastar pharmaceuticals, inc. - tetracosactide - powder for solution - 0.25mg - tetracosactide 0.25mg - adrenocortical insufficiency

COSACTHEN SOLUTION Kanada - Ingliż - Health Canada

cosacthen solution

dechra ltd - tetracosactide - solution - 0.25mg - tetracosactide 0.25mg - dogs

Cosacthen 0.25 mg/ml Solution for Injection for Dogs Ingilterra - Ingliż - VMD (Veterinary Medicines Directorate)

cosacthen 0.25 mg/ml solution for injection for dogs

dechra regulatory bv - tetracosactide - solution for injection - hormone - dogs

SYNACTHEN DEPOT 1 MG/ML Iżrael - Ingliż - Ministry of Health

synacthen depot 1 mg/ml

novartis pharma services ag - tetracosactide hexaacetate 1 mg/ml - suspension for injection - tetracosactide - collagen diseases, neurological diseases, chronic skin disorders.

SYNACTHEN DEPOT injection Għarabja Sawdita - Ingliż - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

synacthen depot injection

mallinckrodt specialty pharmaceuticals, ireland - tetracosactide (tetracosactrin) - injection - 1 mg/ml